Page last updated: 2024-09-03

amarogentin and Atherosclerosis

amarogentin has been researched along with Atherosclerosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chandel, S; Dixit, M; Gromiha, MM; Manoj, N; Mehta, N; Potunuru, UR; Priya, KV; Raman, T; Ramar, M; Varsha, MKNS1

Other Studies

1 other study(ies) available for amarogentin and Atherosclerosis

ArticleYear
Amarogentin, a secoiridoid glycoside, activates AMP- activated protein kinase (AMPK) to exert beneficial vasculo-metabolic effects.
    Biochimica et biophysica acta. General subjects, 2019, Volume: 1863, Issue:8

    Topics: AMP-Activated Protein Kinases; Animals; Atherosclerosis; Calorimetry; Diabetes Mellitus, Experimental; Endothelium, Vascular; Enzyme Activation; Glucose; Human Umbilical Vein Endothelial Cells; Humans; Iridoids; Lipids; Male; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Rats; Signal Transduction; Tumor Necrosis Factor-alpha

2019